Research Topics
| Paula LumSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, CaliforniaPaulo Telles Dias
Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas NEPAD Universidade do Estado do Rio de Janeiro State University of Rio de Janeiro, 20940 200 Rio de Janeiro, RJ, Brasil
BMC Infect Dis 11:208. 2011..In the United States (U.S.) HCV GT 1 is reported as the most common infecting GT among chronically infected patients. In Europe, however, recent studies have suggested that the epidemiology of HCV GTs is changing...
Hepatitis B virus infection and immunization status in a new generation of injection drug users in San FranciscoP J Lum
Department of Medicine, University of California, San Francisco, CA, USA
J Viral Hepat 15:229-36. 2008..Until the broad effects of universal vaccination are seen, targeted and innovative approaches to immunizing young IDU in the US are needed to prevent a substantial number of new HBV infections...- Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settingsPaula J Lum
Department of Medicine, HIV AIDS Division, University of California, San Francisco, San Francisco, CA, USA
J Acquir Immune Defic Syndr 56:S91-7. 2011..Pain syndromes are common in HIV-infected patients, who also are commonly affected by opioid-use disorders. Although opioids can treat pain, prescribers must consider the consequences of iatrogenic or missed addiction diagnoses... - Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO StudyPaula J Lum
Positive Health Program, Department of Medicine, University of California, San Francisco 94143-0874, USA
Am J Public Health 93:919-23. 2003 
The medical management of opioid dependence in HIV primary care settingsPaula J Lum
Positive Health Program, Department of Medicine, University of California, San Francisco General Hospital, CA 94110, USA
Curr HIV/AIDS Rep 3:195-204. 2006..Buprenorphine, a partial opioid agonist approved for the office-based treatment of opioid dependence in 2002, may result in better health and substance use treatment outcomes for patients with HIV disease...- Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO StudyAline Inglez-Dias
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94105, USA
Drug Alcohol Rev 27:286-91. 2008..To describe temporal trends in methamphetamine use among young injection drug users (IDU) in San Francisco... - Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfectionKimberly Page
University of California, San Francisco, San Francisco, CA 94105, USA
Clin Infect Dis 56:405-13. 2013..Detection of hepatitis C virus (HCV) reinfection and intercalation (ie, intermittent recurrent bouts of viremia with homologous virus interspersed with aviremic periods) requires extensive and frequent evaluation and viral sequencing... - Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistanceGrant Nash Colfax
AIDS Office, San Francisco Department of Public Health, San Francisco, California, USA
AIDS 21:239-41. 2007..We postulate that this association may be caused by methamphetamine-associated treatment interruptions among source partners... - Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San FranciscoOliver Bacon
Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, and the Positive Health Program, Department of Medicine, San Francisco General Hospital, California 94105, USA
Sex Transm Dis 33:228-34. 2006..HIV prevention among MSM-IDU must be tailored to address the excess risk associated with sex work... - Clinical presentation and course of acute hepatitis C infection in HIV-infected patientsAnnie Luetkemeyer
HIV AIDS Division, San Francisco General Hospital, University of California at San Francisco, CA 94110, USA
J Acquir Immune Defic Syndr 41:31-6. 2006..Unexplained transaminase elevations in HIV-infected patients, including men who have sex with men, should trigger an evaluation for acute HCV infection... - Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)Jennifer L Evans
Prevention and Public Health Group, Department of Epidemiology and Biostatistics, University of California, San Francisco, 50 Beale St, Suite 1200, San Francisco, CA 94105, USA
Drug Alcohol Depend 101:152-7. 2009..Studies of injection drug use cessation have largely sampled adults in drug treatment settings. Little is known about injection cessation and relapse among young injection drug users (IDU) in the community... - Hepatitis C virus risk behaviors within the partnerships of young injecting drug usersJudith A Hahn
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
Addiction 105:1254-64. 2010..We sought to determine whether perceiving one's injecting partner to be HCV positive was associated with decreased odds of engaging in receptive needle/syringe sharing (RNS) or ancillary equipment sharing (AES) with that partner... - Traveling young injection drug users at high risk for acquisition and transmission of viral infectionsJudith A Hahn
Department of Medicine, University of California, San Francisco, CA 94143, USA
Drug Alcohol Depend 93:43-50. 2008..Young injection drug users (IDU) are highly mobile. It is not known how mobility affects their risk of acquiring and transmitting viral infections... - Injection risk behavior among women syringe exchangers in San FranciscoPaula J Lum
The Positive Health Program, Department of Medicine, University of California, San Francisco, California 94143-0936, USA
Subst Use Misuse 40:1681-96. 2005..Additional efforts to reduce risky injection practices should focus on younger and homeless female IDU, as well as address selective risk taking between sexual partners... - Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)Jennifer L Evans
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94105, USA
J Urban Health 80:137-46. 2003..Interventions to reduce sexual and injection practices that put women at risk of contracting hepatitis and HIV are needed... - Hepatitis C virus seroconversion among young injection drug users: relationships and risksJudith A Hahn
Department of Epidemiology, University of California, San Francisco, 94110, USA
J Infect Dis 186:1558-64. 2002..Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk... - Prevalence and correlates of HIV infection among young injection drug users in San FranciscoKimberly Page Shafer
Center for AIDS Prevention Studies, Department of Medicine, University of California at San Francisco, 94105, USA
J Acquir Immune Defic Syndr 31:422-31. 2002..We assessed the prevalence of HIV infection and associated risk behaviors among street-recruited young injection drug users (IDUs) in San Francisco... - Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfectionKimberly Page
Department of Epidemiology and Biostatistics, University of California, San Francisco, 50 Beale St, Ste 1200, San Francisco, CA 94105, USA
J Infect Dis 200:1216-26. 2009..Hepatitis C virus (HCV) infection, clearance, and reinfection are best studied in injection drug users (IDUs), who have the highest incidence of HCV and are likely to represent most infections... - Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?Vivian Levy
San Mateo County Health Systems, San Mateo, CA, USA
Vaccine 28:5947-51. 2010..Educational strategies will be needed to ensure understanding of key concepts prior to implementing HCV vaccine trials... - Preventing hepatitis C virus infection in injection drug users: risk reduction is not enoughKimberly Page-Shafer
AIDS 21:1967-9. 2007
Research Grants
- A Randomized Trial of Vaccine Adherence in Young IDUPaula Lum; Fiscal Year: 2006..abstract_text> ..